摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Dothiepin | 25627-37-6

中文名称
——
中文别名
——
英文名称
Dothiepin
英文别名
(E)-N,N-dimethyl-3-(6,11-dihydrodibenzothiepin-11-ylidene)propylamine;trans-Dothiepin;trans-11-(3-dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepin;Dosulepin;(3E)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-N,N-dimethylpropan-1-amine
Dothiepin化学式
CAS
25627-37-6
化学式
C19H21NS
mdl
——
分子量
295.448
InChiKey
PHTUQLWOUWZIMZ-GZTJUZNOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    171-172 °C
  • 熔点:
    55-57 °C
  • 溶解度:
    In water, 1.5 mg/L @ 25 °C /Estimated/
  • 蒸汽压力:
    4.3X10-7 mm Hg @ 25 °C /Estimated/
  • 保留指数:
    2364;2385;2376.1;2380;2380;2382

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    28.5
  • 氢给体数:
    0
  • 氢受体数:
    2

ADMET

代谢
度洛西平在肝脏中经历广泛的代谢,形成主要代谢物N-去甲基衍生物诺西aden(去甲基度洛西平或诺西aden)和度洛西平S-氧化物。诺西aden S-氧化物是尿液中发现的12种基本代谢物之一。度洛西平的代谢途径被认为涉及N-去甲基化、S-氧化和葡萄糖醛酸结合。
Dosulepin undergoes extensive hepatic metabolism, to form main metabolites N-demethylated derivative northiaden (desmethyldosulepin or northiaden) and dosulepin S-oxide. Northiaden S-oxide is among 12 basic metabolites that are found in urine. The metabolic pathways of dosulepin is thought to involve N-demethylation, S-oxidation and glucuronic acid conjugation.
来源:DrugBank
代谢
多塞平-X-氧化物是主要的代谢物。诺思亚登(去甲基多塞平)是一种N-去甲基衍生物。这两种代谢物都具有抗抑郁活性。
Dothiepin-X-oxide is the major metabolite. Northiaden (desmethyl-dothiepin) is an N-demethylated derivative. Both metabolites have antidepressant activity.
来源:Hazardous Substances Data Bank (HSDB)
代谢
27名健康男性在三组随机交叉剂量比例研究中,分别单次口服50毫克、100毫克和150毫克盐酸多塞平胶囊。多塞平的三个主要代谢物,即多塞平的S-氧化物衍生物、N,N-二甲基[b,e]噻吩-delta 11(6 H)、γ-丙基胺5-氧化物(2)、脱甲基衍生物、N-甲基二苯[b,e]噻吩-delta 11(6 H)、γ-丙基胺(3)和脱甲基S-氧化物衍生物N-甲基二苯[b,e]噻吩-delta 11(6 H)、γ-丙基胺5-氧化物(4)的血浆浓度-时间曲线由一个一室模型描述,该模型具有明显的一阶形成。S-氧化物2和脱甲基S-氧化物4的AUC无限值随着剂量的增加而成比例增加。从本研究数据中可能无法确定脱甲基代谢物3的剂量比例性。三个代谢物的相应半衰期,与剂量无关,分别大约为24小时、28小时和40小时。/盐酸多塞平/
Twenty-seven healthy men received three single oral doses of 50-, 100-, and 150-mg dothiepin hydrochloride capsules in a three-way randomized, crossover dose-proportionality study. ... Plasma concentration-time profiles of the three major metabolites of dothiepin, the S-oxide derivative of dothiepin, N,N-dimethyl[b,e]thiepin-delta 11(6 H), gamma-propylamine 5-oxide (2), the demethyl derivative, N-methyldibenzo[b,e]thiepin-delta 11(6 H), gamma-propylamine (3) and the demethyl S-oxide derivative N-methyldibenzo[b,e]thiepin-delta 11(6 H), gamma-propylamine 5-oxide (4), were described by a one-compartment model with apparent first-order formation. The AUC infinity values of the S-oxide 2 and the demethyl S-oxide 4 increased proportionally with dose. The dose proportionality of the demethyl metabolite 3 may not be ascertained from the data in this study. The corresponding half-lives of the three metabolites, which are dose independent, were approximately 24, 28, and 40 hr, respectively. /Dothiepin Hydrochloride/
来源:Hazardous Substances Data Bank (HSDB)
代谢
在72小时内,只有少量未结合的多塞平(未改变的药物)和诺斯替丁被排泄在尿液中。超过10%的剂量以结合多塞平形式排泄,少于0.8%的剂量以结合诺斯替丁形式排泄。因此,结合多塞平被认为是多塞平的重要代谢物。结合多塞平和诺斯替丁被β-葡萄糖醛酸酶水解,并分别用1,4-糖酸内酯抑制其水解。发现结合多塞平和诺斯替丁分别是季铵链接的葡萄糖醛酸苷和叔N-葡萄糖醛酸苷。
Only small amounts of unconjugated dothiepin (unchanged drug) and northiaden were excreted in urine over a 72 hr period. More than 10% of the dose was excreted as conjugated dothiepin and less than 0.8% of the dose as conjugated northiaden. Conjugated dothiepin was thus found to be an important metabolite of dothiepin. Conjugated dothiepin and northiaden were hydrolyzed with beta-glucuronidase, and their hydrolysis inhibited with 1,4 saccharolactone. Conjugated dothiepin and northiaden were found to be a quaternary ammonium-linked glucuronide and a tertiary N-glucuronide, respectively.
来源:Hazardous Substances Data Bank (HSDB)
代谢
... 去甲地芬太尼和盐酸多塞平S-氧化物(盐酸多塞平的两个代谢物)的血浆和血药浓度进行了测量。盐酸多塞平S-氧化物是主要的代谢物,达到81(34-150)ug/l的峰值水平,在5(4-6)小时。相比之下,去甲地芬太尼在5(4-9)小时只达到了10(3-21)ug/l的峰值浓度。盐酸多塞平S-氧化物的平均消除半衰期是19(13-35)小时,而去甲地芬太尼的平均消除半衰期是33(22-60)小时。
... Plasma and blood concentrations of northiaden and blood concentrations of dothiepin S-oxide, two metabolites of dothiepin, were measured. Dothiepin S-oxide was the major metabolic reaching a peak level of 81 (34-150) ug/l at 5 (4-6) hr. In comparison, northiaden reached a peak concentration of only 10 (3-21) ug/l at 5 (4-9) hr. The mean half-life of elimination of dothiepin S-oxide was 19 (13-35) hr while that for northiaden was 33 (22-60) hr.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 在妊娠和哺乳期间的影响
哺乳期使用概述:多塞平未获得美国食品药品监督管理局在美国的上市批准,但在其他国家可用。有限的信息表明,母亲每日剂量高达225毫克时,在乳汁和哺乳婴儿的血清中产生的水平较低,并且不会导致不良发育后果。多塞平预计不会对哺乳婴儿产生任何不良影响,特别是如果婴儿年龄超过2个月。 对哺乳婴儿的影响:八位因抑郁症接受多塞平治疗的妇女哺乳了她们的婴儿(具体程度未说明),婴儿年龄为0.13至12.5个月。母亲用药剂量为每日25至225毫克(每日0.38至4.5毫克/千克)。没有任何婴儿出现明显的不良反应。 一项回顾性病例对照研究对15位在哺乳期服用多塞平治疗抑郁症的母亲进行了调查,将她们的婴儿与一组15位未在哺乳期服用抗抑郁药的抑郁母亲以及另外36位没有抑郁症的母亲所生的婴儿的神经认知结果进行了比较。服用多塞平的母亲在哺乳期间每日剂量为150至225毫克,持续时间为4至134周。婴儿在哺乳期间通过母乳接触多塞平的时间为3至152周,并在3至5岁时进行了评估。没有证据表明对婴儿发育有负面影响,使用了许多评分量表。 两名婴儿在母亲使用多塞平期间哺乳了7至18周。两种药物都是在婴儿8周大时开始使用的。一位母亲开始时服用每日50毫克的剂量,后增加到每日100毫克;她在哺乳期间服用了33周的多塞平。另一位母亲每日服用225毫克,并在哺乳期间为她的婴儿哺乳了25周。正式测试表明,直到30个月大,婴儿的发育没有受到不良影响。 对泌乳和母乳的影响:一名服用多塞平的妇女报告出现乳汁过多。 一项观察性研究调查了在怀孕前两年内服用抗抑郁药的2859名妇女的结局。与怀孕期间未服用抗抑郁药的妇女相比,整个孕期(三个季度)服用抗抑郁药的妇女出院时哺乳的可能性降低了37%。仅在第三季度服用抗抑郁药的妇女出院时哺乳的可能性降低了75%。仅在第一季度和第二季度服用抗抑郁药的妇女出院时哺乳的可能性没有降低。母亲使用的抗抑郁药未具体说明。 一项回顾性队列研究调查了2001年至2008年的医院电子医疗记录,比较了在晚期妊娠期间被开出抗抑郁药的妇女(n = 575)与患有精神疾病但未接受抗抑郁药的妇女(n = 1552)以及没有精神疾病诊断的妇女(n = 30,535)。服用抗抑郁药的妇女出院时哺乳的可能性比没有精神疾病诊断的妇女低37%,但与未接受治疗的患有精神疾病的母亲相比,哺乳的可能性没有降低。所有母亲都没有服用多塞平。 在一项对1999年至2008年的80,882对挪威母婴对的研究中,有392位妇女报告在产后期新开始使用抗抑郁药,201位报告她们从怀孕期间继续使用抗抑郁药。与未暴露的对照组相比,晚期妊娠使用抗抑郁药与哺乳开始的几率降低7%有关,但对哺乳持续时间和专一性没有影响。与未暴露的对照组相比,新开始或重新开始使用抗抑郁药与在6个月时主要哺乳的几率降低63%,任何哺乳的几率降低51%,以及突然停止哺乳的风险增加2.6倍有关。具体抗抑郁药未提及。
◉ Summary of Use during Lactation:Dothiepin is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. Limited information indicates that maternal doses of up to 225 mg daily produce low levels in milk and breastfed infants' serum, and cause no adverse developmental consequences. Dothiepin would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. ◉ Effects in Breastfed Infants:Eight women who were receiving dothiepin for depression breastfed (extent not stated) their infants aged 0.13 to 12.5 months of age. Maternal dosages ranged from 25 to 225 mg daily (0.38 to 4.5 mg/kg daily). None of the infants had any noticeable adverse reactions. A retrospective, case-control study of 15 women who breastfed while taking dothiepin for depression compared the neurocognitive outcomes of their infants to those in a group of 15 depressed mothers who had not taken an antidepressant during breastfeeding and another 36 women without depression. The mothers in the dothiepin group had taken dosages of 150 to 225 mg daily for 4 to 134 weeks during breastfeeding. Infants had been exposed to dothiepin in breast milk at times from 3 to 152 weeks of age and were assessed at 3 to 5 years of age. There was no evidence of negative effects on the infants' development using a number of rating scales. Two infants were breastfed for 7 to 18 weeks during maternal use of dothiepin. The drug was started when both infants were 8 weeks of age. One mother started with a dose of 50 mg daily that was increased to 100 mg daily; she took dothiepin for 33 weeks during breastfeeding. The other mother was taking 225 mg daily and nursed her infant for 25 weeks during breastfeeding. Formal testing indicated no adverse effects on infant development up to 30 months of age. ◉ Effects on Lactation and Breastmilk:Galactorrhea has been reported in one woman taking dothiepin. An observational study looked at outcomes of 2859 women who took an antidepressant during the 2 years prior to pregnancy. Compared to women who did not take an antidepressant during pregnancy, mothers who took an antidepressant during all 3 trimesters of pregnancy were 37% less likely to be breastfeeding upon hospital discharge. Mothers who took an antidepressant only during the third trimester were 75% less likely to be breastfeeding at discharge. Those who took an antidepressant only during the first and second trimesters did not have a reduced likelihood of breastfeeding at discharge. The antidepressants used by the mothers were not specified. A retrospective cohort study of hospital electronic medical records from 2001 to 2008 compared women who had been dispensed an antidepressant during late gestation (n = 575) to those who had a psychiatric illness but did not receive an antidepressant (n = 1552) and mothers who did not have a psychiatric diagnosis (n = 30,535). Women who received an antidepressant were 37% less likely to be breastfeeding at discharge than women without a psychiatric diagnosis, but no less likely to be breastfeeding than untreated mothers with a psychiatric diagnosis. None of the mothers were taking dothiepin. In a study of 80,882 Norwegian mother-infant pairs from 1999 to 2008, new postpartum antidepressant use was reported by 392 women and 201 reported that they continued antidepressants from pregnancy. Compared with the unexposed comparison group, late pregnancy antidepressant use was associated with a 7% reduced likelihood of breastfeeding initiation, but with no effect on breastfeeding duration or exclusivity. Compared with the unexposed comparison group, new or restarted antidepressant use was associated with a 63% reduced likelihood of predominant, and a 51% reduced likelihood of any breastfeeding at 6 months, as well as a 2.6-fold increased risk of abrupt breastfeeding discontinuation. Specific antidepressants were not mentioned.
来源:Drugs and Lactation Database (LactMed)
毒理性
  • 相互作用
癫痫或心律失常可能会在服用大量循环性抗抑郁药的患者中由氟马西尼诱发。/氟马西尼/
Seizures or arrhythmias may be precipitated /SRP: by flumazenil/ in patients with a serious cyclic antidepressant overdose. /Flumazenil/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
蛋白质的高度结合以及广泛的分布体积,往往排除了血液透析和血液灌流的潜在有用性。
The high degree of protein binding, together with the extensive volume of distribution, tends to preclude the potential usefulness of hemodialysis and hemoperfusion.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
在服用多塞平过量导致心室颤动和心脏骤停后,一名成人接受了静脉注射碳酸氢钠、多巴胺和利多卡因以及过度通气的治疗。他的病情仍然不稳定。一小时后,静脉注射氯化钠……在5分钟内给药。血压立即上升;QRS复合波变窄,心脏异常变得不那么频繁。在接下来的几天里,类似的低血压和心脏异常的发作通过快速输注氯化钠得到了逆转。
Following a dothiepin overdose leading to ventricular fibrillation and cardiac arrest, an adult was treated with intravenous sodium bicarbonate, dopamine, and lidocaine with hyperventilation. His condition remained unstable. One hour later, intravenous sodium chloride ... was given over 5 minutes. The blood pressure rose immediately; the QRS complexes narrowed and cardiac abnormalities became less frequent. Similar episodes of hypotension and cardiac abnormalities over the following days were reversed by rapid infusion of sodium chloride.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
治疗主要包括洗胃和服用活性炭(单次或多次剂量)。尽管使用活性炭表明它在降低多塞平半衰期方面发挥作用,但其他关于三环类抗抑郁药的研究显示半衰期几乎没有显著降低。
Treatment consists largely of gastric lavage and activated charcoal (either single or multiple doses). Although use of activated charcoal suggests a role in decreasing the half-life of dothiepin, other studies with TCAs show little or no such significant decrease in half-life.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
  • 吸收
度洛西汀从肠道吸收良好,在口服25毫克后2.18小时(Tmax)达到37.6纳克/毫升的血浆峰浓度。由于药物剂量与血浆浓度之间的动态关系,个体的稳态浓度各不相同。
Dosulepin is well absorbed from the intestines to reach the peak plasma concentration of 37.6ng/mL at 2.18 hours (Tmax) following oral administration of 25mg. The steady state concentrations are variable among individuals due to dynamic relationship between the drug dose and plasma concentration.
来源:DrugBank
吸收、分配和排泄
  • 消除途径
度洛西平主要通过肾脏消除,主要是以代谢物的形式。度洛西平和其代谢物的肾脏排泄占总消除的50%-60%,胆汁/粪便排泄约占15%-40%。
Dosulepin is predominantly cleared via renal elimination, mainly in the form of metabolites. Renal excretion of dosulepin and its metabolites accounts for 50% - 60% of total elimination, and biliary/fecal excretion is about 15%-40%.
来源:DrugBank
吸收、分配和排泄
  • 分布容积
平均表观分布容积约为45 L/kg,在口服75毫克多塞平后。它穿过血脑屏障以介导其抗抑郁作用,并且也穿过胎盘屏障,药物在母乳中的排泄浓度较低。
The mean apparent Vd is approximately 45 L/kg after oral administration of 75mg dosulepin. It crosses the blood-brain barrier to mediate its antidepressant actions and also crosses the placental barriers, with low concentration of the drug excreted in breast milk.
来源:DrugBank
吸收、分配和排泄
  • 清除
口腔清除率大约为1.36升/千克
Oral clearance is approximately 1.36 L/kg
来源:DrugBank
吸收、分配和排泄
多塞平及其代谢物已在母乳中被检测到。婴儿每天的总平均暴露量大约占母亲多塞平剂量的4.4%。
Dothiepin and its metabolites have been detected in breast milk. The mean total daily infant exposure amounts to about 4.4% of the maternal dothiepin dosage.
来源:Hazardous Substances Data Bank (HSDB)

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Dothiepin双氧水 以24%的产率得到
    参考文献:
    名称:
    RAYSNER M.; BARTL V.; SINDELAR K.; SVATEK E.; HOLUBEK J.; METYS J.; PROTI+, COLLECT. CZECH. CHEM. COMMUN., 1979, 44, NO 8, 2536-2549
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-(6,11-dihydrodibenzothiepin-11-ylidene)propionitrile氢氧化钾 、 lithium aluminium tetrahydride 、 氯化亚砜 作用下, 以 乙醚乙醇 为溶剂, 反应 10.83h, 生成 Dothiepin
    参考文献:
    名称:
    Polivka, Zdenek; Licha, Irena; Taufmann, Petr, Collection of Czechoslovak Chemical Communications, 1987, vol. 52, # 6, p. 1566 - 1581
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • The photochemical stability of <i>cis-</i> and <i>trans</i>- isomers of tricyclic neuroleptic drugs
    作者:A Li wan Po、W J Irwin
    DOI:10.1111/j.2042-7158.1980.tb12839.x
    日期:2011.4.12
    Abstract

    The irradiation of the tranquillizers flupenthixol, clopenthixol and chlorprothixene has been found to induce rapid cis-trans isomerization. The composition of the photostationary mixture is not that of the batch drug and hence this process may affect the activity. Further decomposition to a thioxanthone derivative occurs rapidly in the presence of air. Exclusion of oxygen, however, does not prevent further degradation and a slower secondary isomerization is observed on prolonged irradiation. Doxepin and dothiepin also undergo analogous reactions but the isomerizations are much slower and the oxidative degradation yields many products.

    标题:摘要 三种镇静剂氟硫氧噻唑、氯硫氧噻唑和氯丙硫氧噻唑的辐照发现会诱导快速的顺-反异构化。光平衡混合物的组成不同于批量药物,因此这个过程可能会影响其活性。在空气存在的情况下,进一步分解为硫氧噻唑衍生物迅速发生。然而,排除氧气并不能阻止进一步降解,长时间辐照观察到较慢的次级异构化。多塞平和多硫平也会发生类似的反应,但异构化速度较慢,氧化降解产生多种产物。
  • POLIVKA, ZDENEK;PROTIVA, MIROSLAV
    作者:POLIVKA, ZDENEK、PROTIVA, MIROSLAV
    DOI:——
    日期:——
  • POLIVKA, ZDENEK;SEDIVY, ZDENEK;PROTIVA, MIROSLAV
    作者:POLIVKA, ZDENEK、SEDIVY, ZDENEK、PROTIVA, MIROSLAV
    DOI:——
    日期:——
  • COUFALOVA, MARIE
    作者:COUFALOVA, MARIE
    DOI:——
    日期:——
  • PUNCOCHAR, LUDVIK;URBAN, LUDEK;SULOVSKY, JAN
    作者:PUNCOCHAR, LUDVIK、URBAN, LUDEK、SULOVSKY, JAN
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

马来酸甲硫替平 锌,二(N,N-二异壬基氨基甲二硫酸根-S,S')- 达莫替平 西他替平 莫那匹尔马来酸盐 苯并[b][1]苯并硫杂卓 艾洛利康 胰岛素,3-(N-苯乙酰)- 硫平酸 盐酸度硫平杂质 盐酸双舒来平 甲替平 溴化替悼铵 氯马昔巴特 氯氟酰胺 氯替平 曲帕替平 扎托布洛芬 度硫平砜 度琉平 度琉平 巴洛沙韦酯 巴洛沙韦 哌嗪,1-[10,11-二氢-8-(甲硫基)二苯并[b,f]噻庚英-10-基]-4-甲基-,4-氧化 吡啶并[3,2-e]-1,2,4-三嗪-6-羧酸,1,2-二氢-3-甲基-,甲基酯 去甲度硫平S-氧化物 佐替平 二苯并[b,f]噻庚英-2-乙酸,10,11-二氢-a-甲基-10-羰基-,(aS)- 二苯并[b,f]噻吩-3-羧酸 二苯并[B,F]硫杂卓-10(11H)-酮 乙酸,1-苯并噻吩-5-醇 丙基,2-(乙酰氧基)-(9CI) 丁-2-烯二酸;2-(6,11-二氢苯并[c][1]苯并硫杂卓-11-基巯基)-1-(4-甲基哌嗪-1-基)乙酮 丁-2-烯二酸;10-(3-二甲基氨基丙氧基)-5,6-二氢苯并[b][1]苯并硫杂卓-6-醇 N-(8-甲基磺酰基-5,6-二氢苯并[b][1]苯并硫杂卓-6-基)乙烷-1,2-二胺;2,4,6-三硝基苯酚 N-(10,11-二氢-8-(甲基磺酰基)二苯并(b,f)硫杂卓-10-基)-1,2-乙二胺S-氧化物与2,4,6-三硝基苯酚的化合物 N,N-二甲基-3-(2-甲基二苯并[b,e]硫杂卓-11(6H)-亚基)-1-丙胺 8-甲氧基-3,4-二氢苯并[B]硫杂七环-5(2H)-酮 8-甲氧基-10-(1-甲基-4-哌啶基)-10,11-二氢二苯并(b,f)硫杂卓马来酸氢盐 8-氯-3-甲氧基-10-哌嗪基-10,11-二氢二苯并(b,f)硫杂卓马来酸盐 8-氯-10-[(叔-丁基氨基)羰基氧基]-10,11-二氢二苯并[b,f]硫杂卓 8-氯-10-[(乙氧羰基)氨基]-10,11-二氢二苯并[b,f]硫杂卓 7-溴-3,4-二氢-2H-1-苯并硫杂卓-5-酮 7-氯-4-[(3,4-二氯苯基)氨基甲酰]-1,1-二氧代-2,3-二氢苯并[b]硫杂卓-5-醇钠水合物 6-[2-(甲基氨基)乙氧基]-二苯并[b,f]硫杂卓-10(11H)-酮盐酸盐(1:1) 6-(2-二甲基氨基乙氧基)-10,11-二氢二苯并(b,f)硫杂卓-10-醇马来酸氢酯 6,11-二氢二苯并[b,e]硫杂卓-11-酮 6,11-二氢二苯并[b,e]噻频-11-胺 6,11-二氢-N,N-二甲基二苯并[b,e]硫杂卓-11-(1-丙胺) 6,11-二氢-N,N-二甲基二苯并(b,e)硫杂卓-11-丙胺5,5-二氧化物富马酸盐